CYP2G1P (Gene)

Entrez:22952

Description:cytochrome P450 family 2 subfamily G member 1, pseudogene

Predicted to enable heme binding activity and monooxygenase activity. Predicted to be involved in epoxygenase P450 pathway and xenobiotic catabolic process. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View CYP2G1P's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with CYP2G1P.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using CYP2G1P.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for CYP2G1P.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CYP2G1P.

Results found

Linked to

	Label	Description
	GSE185200 GSE185202 L-13 Ali-BL 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE236502 paclitaxel 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 dasatinib 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 11 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 4 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE206510 L-13 epithelial cell 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 11 v 13 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE210476 rutaecarpine macrophage 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE138863 disulfiram 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172494 nicotinamide 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE185200 GSE185202 L-13 Ali-BL 0 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE236502 paclitaxel 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE135514 dasatinib 2 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE239844 crizotinib 11 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE239844 crizotinib 4 v 10 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE206510 L-13 epithelial cell 0 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE111247 temozolomide LN-308 11 v 13 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE210476 rutaecarpine macrophage 2 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE138863 disulfiram 2 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE172494 nicotinamide 2 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.